Aurora Cannabis Inc. (TSX:ACB)
| Market Cap | 360.18M |
| Revenue (ttm) | 367.13M |
| Net Income (ttm) | -57.50M |
| Shares Out | 56.45M |
| EPS (ttm) | -1.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 660,614 |
| Average Volume | 596,471 |
| Open | 6.15 |
| Previous Close | 6.18 |
| Day's Range | 6.11 - 6.47 |
| 52-Week Range | 4.95 - 9.90 |
| Beta | 1.26 |
| RSI | 38.64 |
| Earnings Date | Nov 5, 2025 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, c... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Aurora Cannabis (ACB) Upgraded Amid Positive Growth Prospects
Aurora Cannabis (ACB) Upgraded Amid Positive Growth Prospects
SA analyst upgrades/downgrades: TSLA, ACB, UPS, PLTR
Discover key analyst upgrades for Aurora Cannabis & Tesla amid growth prospects, plus UPS & Palantir downgrades.
Aurora Cannabis: Upgrading On High-Margin Medical Cannabis Sales Growth - Buy
Q2 2026 Aurora Cannabis Inc Earnings Call Transcript
Q2 2026 Aurora Cannabis Inc Earnings Call Transcript
Aurora Cannabis Lifts Outlook As CEO Hails Record Medical Marijuana Growth In Q2
Aurora Cannabis Inc. (NASDAQ: ACB) shares surged after the company reported fiscal second-quarter 2026 results, showing higher revenue and profitability, but a net loss compared to the prior year. Th...
Aurora Cannabis Inc. (ACB:CA) Q2 2026 Earnings Call Transcript
Aurora Cannabis Inc. (ACB:CA) Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - CEO...
Aurora Cannabis (ACB) Reports Strong Q2 Results with 52% EBITDA Growth
Aurora Cannabis (ACB) Reports Strong Q2 Results with 52% EBITDA Growth
Aurora Cannabis in charts: Q2 medical cannabis revenue growth slows, consumer sales decline
Aurora Cannabis reports Q2 results; initiates Q3 outlook
Aurora Cannabis press release (ACB): Q2 Adjusted gross profit before FV adjustments1 was C$51.8 million in Q2 2026 compared to C$42.6 million in the prior year period, an increase of 22%.
Aurora Cannabis Announces Fiscal 2026 Second Quarter Results
Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net Revenue 1 by 22% to Record $42.7 million, with leadership positions across...
Aurora Cannabis (ACB) Prepares for Q2 Earnings Amid Market Volatility
Aurora Cannabis (ACB) Prepares for Q2 Earnings Amid Market Volatility
Aurora Cannabis Q2 preview: What to expect
Top Canadian Cannabis Stocks to Watch in November 2025
The Canadian cannabis market continues to evolve as global demand expands and U.S. legalization remains a hot topic. Investors are watching closely as several major producers position themselves for r...
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q2 2026 Earnings
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q2 2026 Earnings
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.
Cannabis Investing 2025: 3 Pot Stocks to Watch Before November
The cannabis industry continues to evolve as investors prepare for potential U.S. federal reform and international market expansion. Despite short-term volatility, global demand for both medical and r...
Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB , Oct. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, ann...
3 Canadian Cannabis Stocks to Watch as U.S. Legalization Gains Steam in 2025
The Canadian cannabis market continues to play a crucial role in the global marijuana industry. As U.S. legalization efforts gain traction, Canadian producers are positioning themselves for renewed gr...
Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock?
Aurora Cannabis (ACB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down ...
How to play cannabis stocks now: An investor's playbook
Cannabis stocks are in focus after President Trump said CBD could "revolutionize senior healthcare" in a Truth Social post. The comment sent bullish signals through the cannabis space, coming months a...
Aurora Cannabis: President Trump's Video Changes Nothing
Discover how Aurora Cannabis Inc.'s turnaround and Trump's CBD remarks impact its stock, plus new risks to watch for. Click here to read why ACB is a Sell.
Wall Street Breakfast Podcast: Weed Stocks Light Up
Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double dig...
Cannabis stocks move higher after Trump boasts CBD health benefits
Cannabis stocks got a pop on Monday after President Trump shared a video highlighting potential health benefits of CBD, reigniting speculation that his administration could reclassify the drug, CNBC's...
Why is Aurora Cannabis stock soaring today and will it last?
Aurora Cannabis Inc (NASDAQ: ACB) rallied more than 25% this morning after President Trump endorsed cannabidiol (CBD) as potential breakthrough in senior healthcare. In a social media post over the we...
Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.